Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

First in Human, Phase I Trial of ZL-1201 in Subjects With Advanced Cancer

NCT04257617 is registered in ClinicalTrials.gov with Zai Lab (Shanghai) Co., Ltd. as lead sponsor.

NCT NCT04257617
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04257617 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
First in Human, Phase I Trial of ZL-1201 in Subjects With Advanced Cancer
Lead sponsor
Zai Lab (Shanghai) Co., Ltd.
Phase
Phase 1
Overall status
Completed
Start date
May 11, 2020
Completion date
January 19, 2023
Enrollment
37 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

advanced cancer